HK134494A - Substituted release azelastine containing medicaments - Google Patents
Substituted release azelastine containing medicamentsInfo
- Publication number
- HK134494A HK134494A HK134494A HK134494A HK134494A HK 134494 A HK134494 A HK 134494A HK 134494 A HK134494 A HK 134494A HK 134494 A HK134494 A HK 134494A HK 134494 A HK134494 A HK 134494A
- Authority
- HK
- Hong Kong
- Prior art keywords
- azelastine
- release
- containing medicaments
- substituted
- substituted release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Abstract
Azelastine-containing pharmaceutical compositions with controlled release of active substance using a release-delaying component, there being 0.001 to 800 parts of release-delaying component for one part by weight of azelastine (as base), and it also being possible for the azelastine to be in the form of its physiologically tolerated salts, and the rate of azelastine release being between 0.05 and 5 mg per hour.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3813244 | 1988-04-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK134494A true HK134494A (en) | 1994-12-09 |
Family
ID=6352451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK134494A HK134494A (en) | 1988-04-20 | 1994-12-01 | Substituted release azelastine containing medicaments |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0338444B1 (en) |
JP (1) | JP2950845B2 (en) |
AT (1) | ATE97572T1 (en) |
AU (1) | AU3318389A (en) |
CA (1) | CA1325976C (en) |
DE (1) | DE58906232D1 (en) |
DK (1) | DK172235B1 (en) |
ES (1) | ES2060685T3 (en) |
FI (1) | FI891865A (en) |
HK (1) | HK134494A (en) |
HU (1) | HU202403B (en) |
IE (1) | IE62778B1 (en) |
MC (1) | MC2025A1 (en) |
PT (1) | PT90308B (en) |
ZA (1) | ZA892877B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9003903D0 (en) * | 1990-12-07 | 1990-12-07 | Astra Ab | NEW PHARMACEUTICAL FORMULATIONS |
DE4207234A1 (en) * | 1992-03-07 | 1993-09-09 | Asta Medica Ag | NEW AMINOCARBONIC ACID DERIVATIVES WITH ANTIALLERGIC / ANTIASTHMIC EFFECT AND METHOD FOR THE PRODUCTION THEREOF |
JPH0710747A (en) * | 1993-04-28 | 1995-01-13 | Takeda Chem Ind Ltd | Solid preparation and its production |
GB9514842D0 (en) * | 1995-07-20 | 1995-09-20 | Smithkline Beecham Plc | Novel formulation |
JP4138910B2 (en) | 1997-07-02 | 2008-08-27 | 帝國製薬株式会社 | Transdermal preparation containing azelastine hydrochloride with good transdermal absorbability and low skin irritation |
UA67802C2 (en) * | 1998-10-23 | 2004-07-15 | Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. | CONTROLLED-RELEASE FORMULATIONS FOR ORAL ADMINISTRATION CONTAINING cGMP PDE-5 INHIBITOR (VARIANTS), METHOD FOR ITS PREPARATION AND METHOD FOR TREATING ERECTILE DYSFUNCTION |
CZ303495B6 (en) | 1998-11-02 | 2012-10-24 | Elan Pharma International Limited | Multiparticulate modified release composition, use thereof and solid oral dosage form |
HU230828B1 (en) | 1999-10-29 | 2018-08-28 | Euro Celtique Sa | Controlled release hydrocodone formulations |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
HU230875B1 (en) | 2000-10-30 | 2018-11-29 | Euro-Celtique S.A. | Controlled release hydrocodone compositions |
EP1396263A1 (en) * | 2002-08-09 | 2004-03-10 | Warner-Lambert Company | Film coating for tablets and caplets |
JP2006521287A (en) * | 2002-12-20 | 2006-09-21 | エスティ.ジェイムス アソシエイト エルエルシー/フェイバー リサーチ シリーズ | High pressure compression for pharmaceutical formulations |
SI2377557T1 (en) * | 2004-11-24 | 2017-02-28 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
BR112015024234B1 (en) | 2013-03-21 | 2022-11-16 | Eupraxia Pharmaceuticals USA LLC | INJECTED SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION, ITS USE TO DECREASE INFLAMMATION OR CONTROL PAIN AND METHOD FOR FORMING COATED MICROPARTICLES |
BR112018008415A2 (en) | 2015-10-27 | 2018-10-30 | Eupraxia Pharmaceuticals Inc | sustained release formulations of local anesthetics |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE49205T1 (en) * | 1984-09-14 | 1990-01-15 | Asta Pharma Ag | SUBSTITUTE BENZYLPHTHALAZINONE DERIVATIVES. |
-
1989
- 1989-04-11 MC MC892044A patent/MC2025A1/en unknown
- 1989-04-14 EP EP89106685A patent/EP0338444B1/en not_active Expired - Lifetime
- 1989-04-14 ES ES89106685T patent/ES2060685T3/en not_active Expired - Lifetime
- 1989-04-14 DE DE89106685T patent/DE58906232D1/en not_active Expired - Lifetime
- 1989-04-14 AT AT89106685T patent/ATE97572T1/en not_active IP Right Cessation
- 1989-04-19 CA CA000597169A patent/CA1325976C/en not_active Expired - Lifetime
- 1989-04-19 HU HU891912A patent/HU202403B/en not_active IP Right Cessation
- 1989-04-19 ZA ZA892877A patent/ZA892877B/en unknown
- 1989-04-19 FI FI891865A patent/FI891865A/en not_active Application Discontinuation
- 1989-04-19 PT PT90308A patent/PT90308B/en not_active IP Right Cessation
- 1989-04-19 IE IE126389A patent/IE62778B1/en not_active IP Right Cessation
- 1989-04-19 DK DK189189A patent/DK172235B1/en not_active IP Right Cessation
- 1989-04-19 AU AU33183/89A patent/AU3318389A/en not_active Abandoned
- 1989-04-20 JP JP1099031A patent/JP2950845B2/en not_active Expired - Lifetime
-
1994
- 1994-12-01 HK HK134494A patent/HK134494A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0338444A1 (en) | 1989-10-25 |
DK189189A (en) | 1989-10-21 |
ATE97572T1 (en) | 1993-12-15 |
IE891263L (en) | 1989-10-20 |
DE58906232D1 (en) | 1994-01-05 |
FI891865A (en) | 1989-10-21 |
MC2025A1 (en) | 1990-04-25 |
ES2060685T3 (en) | 1994-12-01 |
AU3318389A (en) | 1989-10-26 |
PT90308A (en) | 1989-11-10 |
DK172235B1 (en) | 1998-02-02 |
JP2950845B2 (en) | 1999-09-20 |
HU202403B (en) | 1991-03-28 |
HUT49808A (en) | 1989-11-28 |
FI891865A0 (en) | 1989-04-19 |
PT90308B (en) | 1994-10-31 |
ZA892877B (en) | 1989-12-27 |
IE62778B1 (en) | 1995-02-22 |
CA1325976C (en) | 1994-01-11 |
DK189189D0 (en) | 1989-04-19 |
JPH01311024A (en) | 1989-12-15 |
EP0338444B1 (en) | 1993-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT615754E (en) | SOLID FORMS OF CONTROLLED LIBERATION ORAL ADMINISTRATION FLUPERTINE | |
EP0427247A3 (en) | Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient | |
GR3007202T3 (en) | ||
HK134494A (en) | Substituted release azelastine containing medicaments | |
IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
GR1003711B (en) | Method for preparating pharmaceutical compositions for diadermic use | |
IL85523A (en) | Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it | |
SE8804629A (en) | ||
IL80437A0 (en) | Benzimidazole derivatives and pharmaceutical compositions containing them | |
PT85829A (en) | Therapeutic agents | |
DE3766200D1 (en) | L-DOPA CONTAINING MEDICINAL PRODUCT. | |
PT86186A (en) | Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same | |
GR3006091T3 (en) | ||
GR890100833A (en) | Process for the preparation of a compound with gastric inhibitopy effect | |
DE3474774D1 (en) | Therapeutic compositions for oral use containing stable s-adenosy1-l-methionine salts | |
GB2021409A (en) | Pharmaceutical composition | |
GR3002765T3 (en) | New pharmaceutical compositions for parenteral use containing a calcitonin as the active ingredient | |
HUT50787A (en) | Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds | |
HU9700842D0 (en) | Pharmaceutical compositions based on stabilized lipophyl matrix giving controlled release for the active components | |
EP0380989A3 (en) | Plaster for transdermal administration | |
EP0351876A3 (en) | Composition for potentiating vaccination effect | |
ATE85218T1 (en) | ORAL PHARMACEUTICAL FORM FOR THE TREATMENT OF HYPERTENSION WITH DILTIAZEM HYDROCHLORIDE ONCE DAILY. | |
AU1621888A (en) | Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes | |
GR3031360T3 (en) | Composition based on ibuprofen, for oral usage | |
JO1519B1 (en) | Novel compounds (Novel deravatives of Benzimidazoles active as anti-ulcer agents). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
CHPA | Change of a particular in the register (except of change of ownership) | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20080414 |